BioNTech SE (BNTX)
87.27
+0.56
(+0.65%)
USD |
NASDAQ |
Apr 26, 16:00
87.27
0.00 (0.00%)
After-Hours: 20:00
BioNTech Market Cap: 20.75B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 20.61B |
| April 24, 2024 | 20.94B |
| April 23, 2024 | 21.04B |
| April 22, 2024 | 20.92B |
| April 19, 2024 | 20.64B |
| April 18, 2024 | 20.48B |
| April 17, 2024 | 20.54B |
| April 16, 2024 | 20.53B |
| April 15, 2024 | 20.89B |
| April 12, 2024 | 20.56B |
| April 11, 2024 | 20.68B |
| April 10, 2024 | 21.07B |
| April 09, 2024 | 21.41B |
| April 08, 2024 | 21.23B |
| April 05, 2024 | 21.52B |
| April 04, 2024 | 21.38B |
| April 03, 2024 | 21.58B |
| April 02, 2024 | 21.76B |
| April 01, 2024 | 22.14B |
| March 28, 2024 | 21.93B |
| March 27, 2024 | 22.10B |
| March 26, 2024 | 21.80B |
| March 25, 2024 | 22.11B |
| March 22, 2024 | 21.83B |
| March 21, 2024 | 21.87B |
| Date | Value |
|---|---|
| March 20, 2024 | 21.40B |
| March 19, 2024 | 22.37B |
| March 18, 2024 | 22.11B |
| March 15, 2024 | 21.98B |
| March 14, 2024 | 22.09B |
| March 13, 2024 | 22.33B |
| March 12, 2024 | 22.76B |
| March 11, 2024 | 22.89B |
| March 08, 2024 | 21.70B |
| March 07, 2024 | 21.65B |
| March 06, 2024 | 21.73B |
| March 05, 2024 | 21.52B |
| March 04, 2024 | 21.23B |
| March 01, 2024 | 21.62B |
| February 29, 2024 | 21.15B |
| February 28, 2024 | 21.74B |
| February 27, 2024 | 22.06B |
| February 26, 2024 | 22.23B |
| February 23, 2024 | 22.34B |
| February 22, 2024 | 22.24B |
| February 21, 2024 | 22.05B |
| February 20, 2024 | 21.69B |
| February 16, 2024 | 21.79B |
| February 15, 2024 | 22.09B |
| February 14, 2024 | 21.74B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.885B
Minimum
Oct 14 2019
108.46B
Maximum
Aug 09 2021
31.54B
Average
27.13B
Median
Market Cap Benchmarks
| Pfizer Inc | 143.32B |
| BioVie Inc | 19.54M |
| Autolus Therapeutics PLC | 1.062B |
| Moderna Inc | 41.27B |
| Novavax Inc | 569.61M |
Market Cap Related Metrics
| PE Ratio | 21.26 |
| PS Ratio | 5.113 |
| Price to Book Value | 0.9270 |
| Price to Free Cash Flow | 4.172 |
| Price | 87.27 |
| Earnings Yield | 4.70% |
| Operating PE Ratio | 21.82 |
| Normalized PE Ratio | 19.12 |